P53 codon 72 polymorphism and human papillomavirus type in relation to cervical cancer in South African women

International Journal of Gynecological Cancer

Volumn 12, Issue 4, 2002, Pages 383-388

  Pegoraro, R J ^a   Rom, L ^a   Lanning, P A ^a   Moodley, M ^b   Naiker, S ^b   Moodley, J ^b  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

Black South Africans; Cervical cancer; Human papillomavirus; p53 codon 72

Indexed keywords

ARGININE; PROTEIN P53;

ALLELE; ARTICLE; CANCER RISK; CARCINOGENESIS; CODON; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SOUTH AFRICA; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; VIRUS INFECTION; VIRUS TYPING; WART VIRUS;

AFRICAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CODON; DNA PRIMERS; DNA, VIRAL; FEMALE; GENES, P53; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS; SOUTH AFRICA; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0036330435     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.2002.01109.x     Document Type: Article

References (35)

1. Role of a p53 polymorphism in the development of human papilloma virus-associated cancer
2. p53 codon 72 polymorphism and risk of cervical cancer in UK
3. p53 polymorphism and risk of cervical cancer
4. p53 polymorphism and risk of cervical cancer
5. No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papilloma 16/18 infection
6. p53 codon 72 polymorphism is not a risk factor for carcinogenesis in the Chinese
7. The p53 Arg72Pro polymorphism, human papillomavirus, and invasive squamous cell cervical cancer
8. p53 codon 72 polymorphism does not affect the risk of cervical cancer in patients from northern Italy
9. p53 polymorphism (codon-72) has no correlation with the development and the clinical features of cervical cancer
10. Codon 72 polymorphism of p53 and its association with cervical cancer
11. p53 codon 72 polymorphism and risk of intra-epithelial and invasive cervical neoplasia in Greek women
12. p53 polymorphism and risk of cervical cancer
13. Homozygous arginine-72 in wild type p53 and risk of cervical cancer
14. p53 codon 72 ARG/PRO polymorphism is not related to HPV type or lesion grade in low- and high-grade squamous intra-epithelial lesions and invasive squamous carcinoma of the cervix
15. No evidence of p53 allele-specific predisposition in human papillomavirusassociated cervical cancer
16. p53 polymorphism and risk of cervical cancer
17. p53 polymorphism and human papillomavirus infection in Hong Kong women with cervical cancer
18. Is p53 polymorphism maintained by natural selection?
19. The influence of the p53 codon 72 polymorphism on ovarian carcinogenesis and prognosis
20. Polymorphisms of H-ras-1 and p53 in breast cancer and lung cancer: A meta-analysis
21. Human immunodeficiency virus infection and cancer in South Africa
22. The use of polymerase chain amplification for the detection of genital human papilloma viruses
23. Human papillomavirus infection of the cervix: Relative association of fifteen common anogenital types
24. The p53 codon 72 polymorphism in black South African women and the risk of cervical cancer
25. P53 polymorphism in codon 72 and risk of human papillomavirus-induced cervical cancer: Effect of inter-laboratory variation
26. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
27. The human papillomavirus-16, E7 oncoprotein is able to bind the retinoblastoma gene product
28. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
29. p53 codon 72 polymorphism and various human papillomavirus 16, E6 genotypes are risk factors for cervical cancer development
30. Identification of a novel p53 functional domain that is necessary for efficient growth suppression
31. The polyproline region of p53 is required to activate apoptosis but not growth arrest
32. Structural basis for the binding of proline-rich peptides to SH3 domains
33. Differential regulation of cellular target genes by p53 devoid of the PXXP motifs with impaired apoptotic activity
34. A common polymorphism acts as an intragenic modifier of mutant p53 behaviour
35. Loss of heterozygosity for defined regions on chromosomes 3, 11, and 17 in carcinoma of the uterine cervix